10.3252/pso.eu.18ECE - Endocrine Abstracts4. Madhu SV, Kant S, Holla W, Arora R, Rathi S Unusual...

1
Poster presented at: ECE 2016 248--EP IRENE BERGES-RASO DOI: 10.3252/pso.eu.18ECE.2016 Clinical case reports - Pituitary/Adrenal

Transcript of 10.3252/pso.eu.18ECE - Endocrine Abstracts4. Madhu SV, Kant S, Holla W, Arora R, Rathi S Unusual...

Page 1: 10.3252/pso.eu.18ECE - Endocrine Abstracts4. Madhu SV, Kant S, Holla W, Arora R, Rathi S Unusual presentation of Kallmannn syndrome with contiguous gene deletion in three siblings

Poster

presented at:

ECE

20

16 248--EP

IRENE BERGES-RASO DOI: 10.3252/pso.eu.18ECE.2016

Clinical case reports - Pituitary/Adrenal

10.3252/pso.eu.18ECE - Endocrine Abstracts · i The lingual thyroid is a relatively rare condition with an incidence of 1 in 3000 ... isecond pharyngeal pouch fails to descend leading

10.3252/pso.eu.18ECE - Endocrine Abstracts · i The lingual thyroid is a relatively rare condition with an incidence of 1 in 3000 ... isecond pharyngeal pouch fails to descend leading

10.3252/pso.eu.18ECE - Endocrine Abstracts · Syndrome evaluated in vivo by Diffusion Tensor Imaging (DTI) ... to fiber density, axonal diameter and myelination degree. ... Cluster

10.3252/pso.eu.18ECE - Endocrine Abstracts · Syndrome evaluated in vivo by Diffusion Tensor Imaging (DTI) ... to fiber density, axonal diameter and myelination degree. ... Cluster

10.3252/pso.eu.17ece - Endocrine Abstracts

10.3252/pso.eu.17ece - Endocrine Abstracts

10.3252/pso.eu.18ECE€¦ · (CV=IOO x s.d./mean). AASI, is defined as 1-(diastolic-on-systolic slope), wherein the slope was determined from a DBP vs. SBP plot by a standard regression

10.3252/pso.eu.18ECE€¦ · (CV=IOO x s.d./mean). AASI, is defined as 1-(diastolic-on-systolic slope), wherein the slope was determined from a DBP vs. SBP plot by a standard regression

10.3252/pso.eu.18ECE - endocrine-abstracts.org · Poster 16 presented at: 964--EP Diana Martins DOI: 10.3252/pso.eu.18ECE.2016 Steroid metabolism action

10.3252/pso.eu.18ECE - endocrine-abstracts.org · Poster 16 presented at: 964--EP Diana Martins DOI: 10.3252/pso.eu.18ECE.2016 Steroid metabolism action

NOV 2019 LIL HOLLA PAGE

NOV 2019 LIL HOLLA PAGE

10.3252/pso.eu.18ECE - Endocrine AbstractsAVP and OT stimulate cAMP pathway in hamster kidney oocyte cells overexpressing AVP receptor V2_ OT-GKR added in combination with AVP potentiate

10.3252/pso.eu.18ECE - Endocrine AbstractsAVP and OT stimulate cAMP pathway in hamster kidney oocyte cells overexpressing AVP receptor V2_ OT-GKR added in combination with AVP potentiate

10.3252/pso.eu.18ECE - Endocrine Abstracts · Thoracocenthesis Exudate, no malignant cells. Contrast CT Sugestion of an endobronchic primary lesion with hepatic and adrenal bilateral

10.3252/pso.eu.18ECE - Endocrine Abstracts · Thoracocenthesis Exudate, no malignant cells. Contrast CT Sugestion of an endobronchic primary lesion with hepatic and adrenal bilateral

10.3252/pso.eu.18ECE - endocrine-abstracts.org · Urinary Free Cortisol (UFC) Levels in Patients with Cushing's Disease: Results From a Randomised, Multicentre, Phase Ill Trial ...

10.3252/pso.eu.18ECE - endocrine-abstracts.org · Urinary Free Cortisol (UFC) Levels in Patients with Cushing's Disease: Results From a Randomised, Multicentre, Phase Ill Trial ...

52--GP - Endocrine Abstracts · Poster 16 presented at: 52--GP Kirstin Andersen DOI: 10.3252/pso.eu.18ECE.2016 Cardiovascular endocrinology

52--GP - Endocrine Abstracts · Poster 16 presented at: 52--GP Kirstin Andersen DOI: 10.3252/pso.eu.18ECE.2016 Cardiovascular endocrinology

Aarti Holla

Aarti Holla

10.3252/pso.eu.18ECE - Endocrine Abstracts fileSevgul FAKII, Oya TOPALOGLUI, Cuneyt BILGINERI Neslihan CUHACII Karabekir ERCAN2 Reyhan ERSOYI, Bekir CAKIRI Ankara Atatürk E§itim

10.3252/pso.eu.18ECE - Endocrine Abstracts fileSevgul FAKII, Oya TOPALOGLUI, Cuneyt BILGINERI Neslihan CUHACII Karabekir ERCAN2 Reyhan ERSOYI, Bekir CAKIRI Ankara Atatürk E§itim

Holla Trails

Holla Trails

Lappset Wall-holla

Lappset Wall-holla

10.3252/pso.eu.18ECE - Endocrine Abstracts€¦ · 40 0 120 O 40 GliGO-48h Ki67 .DRAQ5 Nocodazole [2] Control .Ki67 Double Thymidine GliGO-24h Ki&7 .DRAQ5 Control GO-24 GO-48 S-phase

10.3252/pso.eu.18ECE - Endocrine Abstracts€¦ · 40 0 120 O 40 GliGO-48h Ki67 .DRAQ5 Nocodazole [2] Control .Ki67 Double Thymidine GliGO-24h Ki&7 .DRAQ5 Control GO-24 GO-48 S-phase

The role of immunochemistry in the SDHx mutations in ... · PDF filePoster ECE 2016 presented at: 4-GP Anna Angelousi DOI: 10.3252/pso.eu.18ECE.2016 ... (SDH) mutations in patients

The role of immunochemistry in the SDHx mutations in ... · PDF filePoster ECE 2016 presented at: 4-GP Anna Angelousi DOI: 10.3252/pso.eu.18ECE.2016 ... (SDH) mutations in patients

10.3252/pso.eu.18ECE - Endocrine Abstracts€¦ · 2.27 2.26 2.19 2.44 2.58 median 83.00 81.75 82.00 79.00 78.00 Other parametres after delivery Systolic and diastolic blood pressure

10.3252/pso.eu.18ECE - Endocrine Abstracts€¦ · 2.27 2.26 2.19 2.44 2.58 median 83.00 81.75 82.00 79.00 78.00 Other parametres after delivery Systolic and diastolic blood pressure

10.3252/pso.eu.18ECE€¦ · Poster 16 presented at: 392--EP MIKELE TORINO DOI: 10.3252/pso.eu.18ECE.2016 Clinical case reports - Thyroid/Others

10.3252/pso.eu.18ECE€¦ · Poster 16 presented at: 392--EP MIKELE TORINO DOI: 10.3252/pso.eu.18ECE.2016 Clinical case reports - Thyroid/Others

10.3252/pso.eu.18ECE · 2017-05-12 · Poster 16 presented at: 546--EP Julia K DOI: 10.3252/pso.eu.18ECE.2016 Diabetes therapy

10.3252/pso.eu.18ECE · 2017-05-12 · Poster 16 presented at: 546--EP Julia K DOI: 10.3252/pso.eu.18ECE.2016 Diabetes therapy

10.3252/pso.eu.18ECE - Endocrine Abstracts · 2.27 2.26 2.19 2.44 2.58 median 83.00 81.75 82.00 79.00 78.00 Other parametres after delivery Systolic and diastolic blood pressure were

10.3252/pso.eu.18ECE - Endocrine Abstracts · 2.27 2.26 2.19 2.44 2.58 median 83.00 81.75 82.00 79.00 78.00 Other parametres after delivery Systolic and diastolic blood pressure were